SrasV1, Main, Exploration, bibRecord, 003724

Duration of antibody responses after severe acute respiratory syndrome.

Identifieur interne : 003724 ( Main/Exploration ); précédent : 003723; suivant : 003725

Duration of antibody responses after severe acute respiratory syndrome.

Auteurs : Li-Ping Wu [République populaire de Chine] ; Nai-Chang Wang ; Yi-Hua Chang ; Xiang-Yi Tian ; Dan-Yu Na ; Li-Yuan Zhang ; Lei Zheng ; Tao Lan ; Lin-Fa Wang ; Guo-Dong Liang

Source :

Emerging infectious diseases [ 1080-6059 ] ; 2007.

RBID : pubmed:18258008

Descripteurs français

KwdFr :
- Anticorps antiviraux (immunologie), Anticorps antiviraux (sang), Chine, Humains, Immunoglobuline G (sang), Production d'anticorps (immunologie), Syndrome respiratoire aigu sévère (immunologie), Virus du SRAS (immunologie), Études longitudinales.
MESH :
- immunologie : Anticorps antiviraux, Production d'anticorps, Syndrome respiratoire aigu sévère, Virus du SRAS.
- sang : Anticorps antiviraux, Immunoglobuline G.
- Chine, Humains, Études longitudinales.
Wicri :
- geographic : République populaire de Chine.

English descriptors

KwdEn :
- Antibodies, Viral (blood), Antibodies, Viral (immunology), Antibody Formation (immunology), China, Humans, Immunoglobulin G (blood), Longitudinal Studies, SARS Virus (immunology), Severe Acute Respiratory Syndrome (immunology).
MESH :
- chemical , blood : Antibodies, Viral, Immunoglobulin G.
- chemical , immunology : Antibodies, Viral.
- geographic : China.
- immunology : Antibody Formation, SARS Virus, Severe Acute Respiratory Syndrome.
- Humans, Longitudinal Studies.

Abstract

Among 176 patients who had had severe acute respiratory syndrome (SARS), SARS-specific antibodies were maintained for an average of 2 years, and significant reduction of immunoglobulin G-positive percentage and titers occurred in the third year. Thus, SARS patients might be susceptible to reinfection >or=3 years after initial exposure.

DOI: 10.3201/eid1310.070576
PubMed: 18258008

Affiliations:

République populaire de Chine

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Duration of antibody responses after severe acute respiratory syndrome.</title>
<author><name sortKey="Wu, Li Ping" sort="Wu, Li Ping" uniqKey="Wu L" first="Li-Ping" last="Wu">Li-Ping Wu</name>
<affiliation wicri:level="1"><nlm:affiliation>Shanxi Provincial Center for Disease Control and Prevention, Taiyuan, People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Shanxi Provincial Center for Disease Control and Prevention, Taiyuan</wicri:regionArea>
<wicri:noRegion>Taiyuan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wang, Nai Chang" sort="Wang, Nai Chang" uniqKey="Wang N" first="Nai-Chang" last="Wang">Nai-Chang Wang</name>
</author>
<author><name sortKey="Chang, Yi Hua" sort="Chang, Yi Hua" uniqKey="Chang Y" first="Yi-Hua" last="Chang">Yi-Hua Chang</name>
</author>
<author><name sortKey="Tian, Xiang Yi" sort="Tian, Xiang Yi" uniqKey="Tian X" first="Xiang-Yi" last="Tian">Xiang-Yi Tian</name>
</author>
<author><name sortKey="Na, Dan Yu" sort="Na, Dan Yu" uniqKey="Na D" first="Dan-Yu" last="Na">Dan-Yu Na</name>
</author>
<author><name sortKey="Zhang, Li Yuan" sort="Zhang, Li Yuan" uniqKey="Zhang L" first="Li-Yuan" last="Zhang">Li-Yuan Zhang</name>
</author>
<author><name sortKey="Zheng, Lei" sort="Zheng, Lei" uniqKey="Zheng L" first="Lei" last="Zheng">Lei Zheng</name>
</author>
<author><name sortKey="Lan, Tao" sort="Lan, Tao" uniqKey="Lan T" first="Tao" last="Lan">Tao Lan</name>
</author>
<author><name sortKey="Wang, Lin Fa" sort="Wang, Lin Fa" uniqKey="Wang L" first="Lin-Fa" last="Wang">Lin-Fa Wang</name>
</author>
<author><name sortKey="Liang, Guo Dong" sort="Liang, Guo Dong" uniqKey="Liang G" first="Guo-Dong" last="Liang">Guo-Dong Liang</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:18258008</idno>
<idno type="pmid">18258008</idno>
<idno type="doi">10.3201/eid1310.070576</idno>
<idno type="wicri:Area/PubMed/Corpus">001C14</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001C14</idno>
<idno type="wicri:Area/PubMed/Curation">001C14</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001C14</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001E27</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001E27</idno>
<idno type="wicri:Area/Ncbi/Merge">001B77</idno>
<idno type="wicri:Area/Ncbi/Curation">001B77</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001B77</idno>
<idno type="wicri:Area/Main/Merge">003867</idno>
<idno type="wicri:Area/Main/Curation">003724</idno>
<idno type="wicri:Area/Main/Exploration">003724</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Duration of antibody responses after severe acute respiratory syndrome.</title>
<author><name sortKey="Wu, Li Ping" sort="Wu, Li Ping" uniqKey="Wu L" first="Li-Ping" last="Wu">Li-Ping Wu</name>
<affiliation wicri:level="1"><nlm:affiliation>Shanxi Provincial Center for Disease Control and Prevention, Taiyuan, People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Shanxi Provincial Center for Disease Control and Prevention, Taiyuan</wicri:regionArea>
<wicri:noRegion>Taiyuan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wang, Nai Chang" sort="Wang, Nai Chang" uniqKey="Wang N" first="Nai-Chang" last="Wang">Nai-Chang Wang</name>
</author>
<author><name sortKey="Chang, Yi Hua" sort="Chang, Yi Hua" uniqKey="Chang Y" first="Yi-Hua" last="Chang">Yi-Hua Chang</name>
</author>
<author><name sortKey="Tian, Xiang Yi" sort="Tian, Xiang Yi" uniqKey="Tian X" first="Xiang-Yi" last="Tian">Xiang-Yi Tian</name>
</author>
<author><name sortKey="Na, Dan Yu" sort="Na, Dan Yu" uniqKey="Na D" first="Dan-Yu" last="Na">Dan-Yu Na</name>
</author>
<author><name sortKey="Zhang, Li Yuan" sort="Zhang, Li Yuan" uniqKey="Zhang L" first="Li-Yuan" last="Zhang">Li-Yuan Zhang</name>
</author>
<author><name sortKey="Zheng, Lei" sort="Zheng, Lei" uniqKey="Zheng L" first="Lei" last="Zheng">Lei Zheng</name>
</author>
<author><name sortKey="Lan, Tao" sort="Lan, Tao" uniqKey="Lan T" first="Tao" last="Lan">Tao Lan</name>
</author>
<author><name sortKey="Wang, Lin Fa" sort="Wang, Lin Fa" uniqKey="Wang L" first="Lin-Fa" last="Wang">Lin-Fa Wang</name>
</author>
<author><name sortKey="Liang, Guo Dong" sort="Liang, Guo Dong" uniqKey="Liang G" first="Guo-Dong" last="Liang">Guo-Dong Liang</name>
</author>
</analytic>
<series><title level="j">Emerging infectious diseases</title>
<idno type="eISSN">1080-6059</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Viral (blood)</term>
<term>Antibodies, Viral (immunology)</term>
<term>Antibody Formation (immunology)</term>
<term>China</term>
<term>Humans</term>
<term>Immunoglobulin G (blood)</term>
<term>Longitudinal Studies</term>
<term>SARS Virus (immunology)</term>
<term>Severe Acute Respiratory Syndrome (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps antiviraux (immunologie)</term>
<term>Anticorps antiviraux (sang)</term>
<term>Chine</term>
<term>Humains</term>
<term>Immunoglobuline G (sang)</term>
<term>Production d'anticorps (immunologie)</term>
<term>Syndrome respiratoire aigu sévère (immunologie)</term>
<term>Virus du SRAS (immunologie)</term>
<term>Études longitudinales</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term>
<term>Immunoglobulin G</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>China</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Production d'anticorps</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Antibody Formation</term>
<term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Immunoglobuline G</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Longitudinal Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Chine</term>
<term>Humains</term>
<term>Études longitudinales</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Among 176 patients who had had severe acute respiratory syndrome (SARS), SARS-specific antibodies were maintained for an average of 2 years, and significant reduction of immunoglobulin G-positive percentage and titers occurred in the third year. Thus, SARS patients might be susceptible to reinfection >or=3 years after initial exposure.</div>
</front>
</TEI>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
</list>
<tree><noCountry><name sortKey="Chang, Yi Hua" sort="Chang, Yi Hua" uniqKey="Chang Y" first="Yi-Hua" last="Chang">Yi-Hua Chang</name>
<name sortKey="Lan, Tao" sort="Lan, Tao" uniqKey="Lan T" first="Tao" last="Lan">Tao Lan</name>
<name sortKey="Liang, Guo Dong" sort="Liang, Guo Dong" uniqKey="Liang G" first="Guo-Dong" last="Liang">Guo-Dong Liang</name>
<name sortKey="Na, Dan Yu" sort="Na, Dan Yu" uniqKey="Na D" first="Dan-Yu" last="Na">Dan-Yu Na</name>
<name sortKey="Tian, Xiang Yi" sort="Tian, Xiang Yi" uniqKey="Tian X" first="Xiang-Yi" last="Tian">Xiang-Yi Tian</name>
<name sortKey="Wang, Lin Fa" sort="Wang, Lin Fa" uniqKey="Wang L" first="Lin-Fa" last="Wang">Lin-Fa Wang</name>
<name sortKey="Wang, Nai Chang" sort="Wang, Nai Chang" uniqKey="Wang N" first="Nai-Chang" last="Wang">Nai-Chang Wang</name>
<name sortKey="Zhang, Li Yuan" sort="Zhang, Li Yuan" uniqKey="Zhang L" first="Li-Yuan" last="Zhang">Li-Yuan Zhang</name>
<name sortKey="Zheng, Lei" sort="Zheng, Lei" uniqKey="Zheng L" first="Lei" last="Zheng">Lei Zheng</name>
</noCountry>
<country name="République populaire de Chine"><noRegion><name sortKey="Wu, Li Ping" sort="Wu, Li Ping" uniqKey="Wu L" first="Li-Ping" last="Wu">Li-Ping Wu</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003724 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003724 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:18258008
   |texte=   Duration of antibody responses after severe acute respiratory syndrome.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:18258008" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

Serveur d'exploration SRAS

Duration of antibody responses after severe acute respiratory syndrome.

Duration of antibody responses after severe acute respiratory syndrome.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.